{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:59Z","timestamp":1788480539949,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.numecd.2020.11.014","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T02:14:01Z","timestamp":1605924841000},"page":"886-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Soluble ST2 proteins in male cachectic patients with chronic heart failure"],"prefix":"10.1016","volume":"31","author":[{"given":"Grzegorz","family":"Sobieszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Powr\u00f3zek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Jaroszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Skwarek-Dziekanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansur","family":"Rahnama-Hezavah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ma\u0142ecka-Massalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.numecd.2020.11.014_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/medicina55080484","article-title":"Electrical changes in polish patients with chronic heart failure: preliminary observations","volume":"55","author":"Sobieszek","year":"2019","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.numecd.2020.11.014_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic heart failure: contemporary diagnosis and management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.numecd.2020.11.014_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.numecd.2020.11.014_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCHEARTFAILURE.113.001036","article-title":"Prognostic value of soluble ST2 in the valsartan heart failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"17","key":"10.1016\/j.numecd.2020.11.014_bib5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST 2 in heart failure","volume":"74","author":"Aimo","year":"2019","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"4","key":"10.1016\/j.numecd.2020.11.014_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.crvasa.2015.08.003","article-title":"Cardiac cachexia - up-to-date 2015","volume":"58","author":"G\u0159iva","year":"2016","journal-title":"Cor Vasa"},{"key":"10.1016\/j.numecd.2020.11.014_bib7","doi-asserted-by":"crossref","DOI":"10.5935\/abc.20160142","article-title":"Cardiac cachexia: perspectives for prevention and treatment","author":"Okoshi","year":"2016","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2020.11.014_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/jcm9041021","article-title":"Electrical and hormonal biomarkers in cachectic elderly women with chronic heart failure","volume":"9","author":"Sobieszek","year":"2020","journal-title":"J Clin Med"},{"issue":"27","key":"10.1016\/j.numecd.2020.11.014_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2020.11.014_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2020.11.014_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2020.11.014_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.numecd.2020.11.014_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cardfail.2013.11.003","article-title":"Heart failure therapyinduced early ST2 changes may offer long-term therapy guidance","volume":"19","author":"Breidthardt","year":"2013","journal-title":"JCard Fail"},{"key":"10.1016\/j.numecd.2020.11.014_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chroni\u0107 heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.numecd.2020.11.014_bib15","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ijcard.2013.01.228","article-title":"Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study","volume":"168","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2020.11.014_bib16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCHEARTFAILURE.113.000207","article-title":"Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes","volume":"6","author":"Felker","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.numecd.2020.11.014_bib17","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","article-title":"Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction","volume":"54","author":"Pascual-Figal","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2020.11.014_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/europace\/eur147","article-title":"Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers","volume":"13","author":"Scott","year":"2011","journal-title":"Europace"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:17:22Z","timestamp":1760545042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475320304919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0939475320304919"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2020.11.014","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble ST2 proteins in male cachectic patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}